Table 2.
Post injury (study index) count of CVD hospitalisations and medication use for adults in injury versus uninjured cohorts
| No injury cohort | Injury cohort | |
| CVD hospital admissions disease subgroup* | Hospitalisation count | |
| Rheumatic fever | 73 | 58 |
| Essential hypertension | 279 | 327 |
| Ischaemic heart disease | 4750 | 3827 |
| Pulmonary heart disease | 469 | 407 |
| Other heart disease | 4128 | 3330 |
| Heart failure | 2415 | 2844 |
| Cerebrovascular disease | 1944 | 1978 |
| Disease of arteries | 1132 | 1050 |
| Disease of veins | 1088 | 902 |
| Other circulatory diseases | 503 | 722 |
| CVD medications by ATC subgroups† | Prescription count | |
| Cardiac therapy (C01) | 125 790 | 122 109 |
| Antihypertensives (C02) | 56 811 | 32 513 |
| Diuretics (C03) | 85 338 | 87 686 |
| Beta blocking agents (C07) | 236 605 | 159 882 |
| Calcium channel blockers (C08) | 300 028 | 199 330 |
| Agents–renin–angiotensin system (C09) | 1 038 724 | 594 538 |
| Lipid-modifying agents (C10) | 938 813 | 557 714 |
*CVD primary diagnosis uisng ICD codes in hospital admissions data.
†Identified in PBS claim data.
ATC, Anatomical Therapeutic Chemical Classification; CVD, cardiovascular disease; ICD, International Statistical Classification of Diseases; PBS, Pharmaceutical Benefits Scheme.